Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum
Exploring the Predictors of Constipation and the Effects of a Baduanjin Program on the Symptoms of Constipation in Adults With Chronic Schizophrenia
1 other identifier
interventional
112
1 country
1
Brief Summary
Patients with schizophrenia spectrum have been suffering from constipation due to long-term use of psychotropic medications and changes in physical activity and eating habits caused by diseases. Aim this study was to examine the effectiveness of Baduanjin program in improving the symptoms of intestinal peristalsis and constipation in patients with psychosis. Method:A randomized controlled trial was conducted in tow psychiatric centers in northern Taiwan.The experimental group was provided with an 8- session Baduanjin program for 24 weeks (1 hour, thrice times per week), while the control group received routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 25, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedSeptember 9, 2020
March 1, 2018
9 months
August 25, 2019
September 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Intestinal Peristalsis
Change from Baseline bowel movement of four quadrants of abdomen at 3 months and 6 months
3 months and 6 months
Secondary Outcomes (2)
Changes in Constipation Assessment Scale
3 months and 6 months
Change in Patient Assessment of Constipation Symptoms
3 months and 6 months
Study Arms (2)
Baduanjin program
EXPERIMENTALThe entire program continued for 6 months (December, 2018 to July, 2019), and the intervention was performed for 60 min 3 times per week; particular attention was paid to the disease characteristics of the patients with chronic schizophrenia and to preventing excessive fatigue. Every session began with a 20-min warm-up, followed by 20 min of Baduanjin program, and ended with a cool-down session. The participants were instructed, with the assistance of a video, to practice Baduanjin program in a group by two authors who are experienced in the psychiatric nurses and had been trained in this program.
Control group
NO INTERVENTIONThe control group (CG) received routine care.
Interventions
The entire program continued for 6 months (December, 2018 to July, 2019), and the intervention was performed for 60 min 3 times per week; particular attention was paid to the disease characteristics of the patients with chronic schizophrenia and to preventing excessive fatigue. Every session began with a 20-min warm-up, followed by 20 min of Baduanjin program, and ended with a cool-down session. The participants were instructed, with the assistance of a video, to practice Baduanjin program in a group by two authors who are experienced in the psychiatric nurses and had been trained in this program.
Eligibility Criteria
You may qualify if:
- Comply with the diagnosis of the spectrum.
- Have the willingness to participate in the study and could read, communicate and cooperate with the completion of the consent form and questionnaire.
- The age is 20 to 64 years old.
- No need for any assistance in walking, and the gait is stable.
- Appeared more than 2 times in the past month for more than 3 consecutive days without resolving or routine use of laxatives
You may not qualify if:
- Diagnosis is organic brain disease, alcohol and substance abuse.
- There have been problems with gastrointestinal bleeding or lesions.
- Have a history of extensive abdominal surgery or gastrointestinal surgery.
- There are medical considerations and medical expenses reduction activities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Yang-Ming University
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chiu-Yueh Yang, PhD
Yang Ming National University
- STUDY DIRECTOR
Li-Ru Wang, MSN
National Yang Ming Chiao Tung University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The data of Intestinal Peristalsis in four quadrants were collected by a research assistant.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2019
First Posted
August 28, 2019
Study Start
October 8, 2018
Primary Completion
July 1, 2019
Study Completion
July 1, 2019
Last Updated
September 9, 2020
Record last verified: 2018-03